Abstract:A cancer predisposition mutation can occur during post-zygotic stages resulting in a mosaic mutation pattern across tissues. Mosaic germline mutations such as those affecting RB1, TP53 and AKT1 are important for clinical testing. However, it is challenging to detect mosaic mutation by genome-wide sequencing approaches as a mutant allele present at a low fraction in a germline sample can be caused by either tumor-in-normal contamination or mosaicism. Here we propose a two-step analytical approach to distinguish between these two possibilities. The first involves assessing the level of tumor-in-normal contamination using all clonal somatic mutations identified through the analysis of tumor purity and chromosome ploidy. The second step determines the probability of mosaicism for a candidate variant by calculating the binomial probability of its mutant allele fraction (MAF) under the contamination hypothesis. We applied this process to 1,172 paired tumor-normal pediatric cancer samples analyzed by whole-genome or whole-exome sequencing. Six mosaic variants were identified, including three pathogenic TP53 mutations with a mutant allele fractions (MAF) ranging from 0.2 to 0.3, one RB1 mutation in a retinoblastoma case with a MAF of 0.08, one IDH1 p.R132H mutation in an acute myeloid leukemiaý case with a MAF of 0.21, and one mosaic RYR2 p.E1690D mutation in an osteosarcoma case with a MAF of 0.11. At the same time, we were able to reject three candidate TP53 variants caused by contamination with MAFs ranging from 0.06 to 0.33. All predicted mosaic mutations were verified by ultra deep sequencing at 10,000X coverage. This experience demonstrates the feasibility of detecting germline mosaicism from whole-genome or whole-exome sequencing of paired tumor-normal samples and would caution accurate analysis of tumor-in-normal contamination when evaluating candidate germline mosaicism. Citation Format: Xiaotu Ma, Donald Yergeau, Bhavin Vadodaria, Joy Nakitandwe, John Easton, Sheila Shurtleff, Jinghui Zhang. Analysis of cancer-initiating mosaic mutation in germline samples of pediatric cancer patients by next generation sequencing. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 851.

Identification of Paternal Germline Mosaicism by MicroSeq and Targeted Next‐generation Sequencing

Parental Mosaicism Detection and Preimplantation Genetic Testing in Families with Multiple Transmissions of De Novo Mutations.

Living Birth Following Preimplantation Genetic Testing for Monogenic Disorders to Prevent Low-Level Germline Mosaicism Related Nicolaides–Baraitser Syndrome

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

Case Report: Identification of Maternal Low-Level Mosaicism in the Dystrophin Gene by Droplet Digital Polymerase Chain Reaction

Next-generation sequence-based preimplantation genetic testing for monogenic disease resulting from maternal mosaicism

Clinical Application of Next Generation Sequencing-Based Haplotype Linkage Analysis in the Preimplantation Genetic Testing for Germline Mosaicisms.

MosaicHunter: Accurate Detection of Postzygotic Single-Nucleotide Mosaicism Through Next-Generation Sequencing of Unpaired, Trio, and Paired Samples

Abstract 851: Analysis of Cancer-Initiating Mosaic Mutation in Germline Samples of Pediatric Cancer Patients by Next Generation Sequencing

Detecting Genomic Mosaicism in “de Novo” Genetic Epilepsy by Amplicon-Based Deep Sequencing

[Genetic Analysis of a Mosaic Case with Low Proportion Mutation of TSC2 Gene].

Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications

Parental Somatic Mosaicism Detected During Prenatal Diagnosis

Genomic mosaicism in the pathogenesis and inheritance of a Rett syndrome cohort

Parental Mosaicism in De Novo Neurodevelopmental Diseases

Paternal Low-Level Mosaicism-Caused SATB2-Associated Syndrome

Postzygotic Single-Nucleotide Mosaicisms in Whole-Genome Sequences of Clinically Unremarkable Individuals.

Identification of of a PAX2 Mutation from Maternal Mosaicism Causes Recurrent Renal Disorder in Siblings

Next-generation Sequencing Analysis of Embryos from Mosaic Patients Undergoing in Vitro Fertilization and Preimplantation Genetic Testing.

Genomic Mosaicism in Paternal Sperm and Multiple Parental Tissues in a Dravet Syndrome Cohort

Detectionof Fetal Trisomy 8 Mosaicism with Cell-free Fetal DNA in Maternal Plasma